Effect of Beta-Blockers on Mortality after Myocardial Infarction in Adults with COPD

Published Online: Thursday, January 16, 2014
Follow Pharmacy_Times:
Jennifer Quint, clinical lecturer in epidemiology at the London School of Hygiene and Tropical Medicine, and Liam Smeeth, professor of clinical epidemiology at the London School of Hygiene and Tropical Medicine, discuss their BMJ study of UK COPD patients who have experienced a first myocardial infarction and the impact of beta-blocker therapy on mortality.

Related Articles
Patients who receive statins soon after acute coronary syndrome are 24% less likely to experience unstable angina after 4 months.
Patients adhered to a novel polypill containing 3 cardiovascular medications better than if they received the medications separately, a study suggests.
Program featuring care transition pharmacists shown to reduce hospital readmissions, improve patient satisfaction.
Hospitalization rates for heart disease and stroke have dropped significantly over the past decade.
Latest Issues
$auto_registration$